Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

ExonHit Therapeutics claims novel antitumor compounds in recent patent

May 22, 2003

Bexarotene reported effective in parapsoriasis

May 21, 2003

Isis and Ercole collaborate on antisense drugs that regulate alternative RNA splicing

May 21, 2003

Lilly researchers describe new antitumor agents with utility in colorectal cancer

May 21, 2003

Bioenvision signs agreement with Penn for clofarabine

May 20, 2003

New pyrrolidine-based FTase inhibitors under study at Wyeth

May 20, 2003

ChemGenex completes enrollment in first part of Quinamed phase I/II trial

May 19, 2003

Novel KDR/Tie-2 inhibitors prepared and tested at Aventis

May 19, 2003

Wilex licenses antibody from VU University Medical Center Amsterdam

May 16, 2003

Phase I Davanat trial begins patient dosing

May 16, 2003

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...